American Heart Journal
Volume 148, Issue 2 , Pages 252-253 , August 2004

Left ventricular assist devices as destination therapy for end-stage heart failure

  • Jonathan E.E. Yager, MD

      Affiliations

    • Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA
  • ,
  • G.Michael Felker, MD

      Affiliations

    • Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA

References 

  1. Rose EA, Moskowitz AJ, Packer M, et al.  The REMATCH trial (rationale, design, and end points. Randomized evaluation of mechanical assistance for the treatment of congestive heart failure). Ann Thorac Surg. 1999;67:723–730
  2. Aaronson KD, Eppinger MJ, Dyke DB, et al.  Left ventricular assist device therapy improves utilization of donor hearts. J Am Coll Cardiol. 2002;39:1247–1254
  3. Adams KF, Zannad F. Clinical definition and epidemiology of advanced heart failure. Am Heart J. 1998;135:S204–215
  4. Hunt SA. Current status of cardiac transplantation. JAMA. 1998;280:1692–1698

PII: S0002-8703(04)00408-9

doi: 10.1016/j.ahj.2004.06.013

American Heart Journal
Volume 148, Issue 2 , Pages 252-253 , August 2004